Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy-Reference-Cited by-同舟云学术

Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy

Published:2023-03-22 Issue:4 Volume:37 Page:323-335
ISSN:1172-7047
Container-title:CNS Drugs
language:en
Short-container-title:CNS Drugs

Author:

Bogan Richard K.^ORCID,Foldvary-Schaefer Nancy^ORCID,Skowronski Roman,Chen Abby,Thorpy Michael J.

Funder

Jazz Pharmaceuticals

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Psychiatry and Mental health,Neurology (clinical)

Link

https://link.springer.com/content/pdf/10.1007/s40263-023-00992-y.pdf

Reference31 articles.

1. Silber MH, Krahn LE, Olson EJ, Pankratz VS. The epidemiology of narcolepsy in Olmsted County, Minnesota: a population-based study. Sleep. 2002;25(2):197–202.

2. Longstreth WT Jr, Ton TG, Koepsell T, Gersuk VH, Hendrickson A, Velde S. Prevalence of narcolepsy in King County, Washington, USA. Sleep Med. 2009;10(4):422–6. https://doi.org/10.1016/j.sleep.2008.05.009.

3. Vignatelli L, Antelmi E, Ceretelli I, Bellini M, Carta C, Cortelli P, et al. Red Flags for early referral of people with symptoms suggestive of narcolepsy: a report from a national multidisciplinary panel. Neurol Sci. 2019;40(3):447–56. https://doi.org/10.1007/s10072-018-3666-x.

4. Acquavella J, Mehra R, Bron M, Suomi JMH, Hess GP. Prevalence of narcolepsy, other sleep disorders, and diagnostic tests from 2013–2016: insured patients actively seeking care. J Clin Sleep Med. 2020;16(8):1255–63.

5. Narcolepsy type 2. The International Classification of Sleep Disorders 3rd ed. Darien, IL: American Academy of Sleep Medicine; 2014.

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. RESTORE: Once-nightly oxybate dosing preference and nocturnal experience with twice-nightly oxybates;Sleep Medicine: X;2024-12

2. Hits and misses with animal models of narcolepsy and the implications for drug discovery;Expert Opinion on Drug Discovery;2024-05-15

3. Dosing Optimization of Low-Sodium Oxybate in Narcolepsy and Idiopathic Hypersomnia in Adults: Consensus Recommendations;Neurology and Therapy;2024-04-25

4. Effects of oxybate dose and regimen on disrupted nighttime sleep and sleep architecture;Sleep Medicine;2024-02

5. Long-term efficacy and safety of low-sodium oxybate in an open-label extension period of a placebo-controlled, double-blind, randomized withdrawal study in adults with idiopathic hypersomnia;Journal of Clinical Sleep Medicine;2023-10